Potassium Citrate Tablet, Extended Release
Product Images NDC 72162-2120

Product Visual Gallery

This gallery contains 3 technical images submitted to the FDA as part of the official labeling for Potassium Citrate (NDC 72162-2120). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Bryant Ranch Prepack, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Structure (Structure)

Chemical structure diagram of Potassium Citrate showing three potassium carboxylate groups attached to a central carbon, with a water molecule indicated (hydrate form).*

FDA Label Image

Table 1. (Table 1.)

A data table titled 'Effect of Potassium Citrate In Patients With Calcium Oxalate Nephrolithiasis' showing stones formed per year across four patient groups. Columns include baseline, on treatment, remission percentage, and any decrease percentage. Remission is defined as the percentage of patients remaining free of newly formed stones during treatment.*

FDA Label Image

Label (Lbl721622120)

Potassium Citrate Extended-Release Tablets USP, 10 mEq (1080 mg) per tablet, shown on a product label. The label states the tablets are uncoated, capsule-shaped, off white to tan yellowish in color, with a package quantity of 100 tablets. It is labeled by Bryant Ranch Prepack and manufactured by Ascent Pharmaceuticals.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.